Dose-escalating, phase 2 safety study of oral lisdexamfetamine in adults with methamphetamine dependence

Trial Profile

Dose-escalating, phase 2 safety study of oral lisdexamfetamine in adults with methamphetamine dependence

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Lisdexamfetamine (Primary)
  • Indications Drug abuse; Drug dependence
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Lisdex
  • Most Recent Events

    • 20 Jun 2017 Status changed from recruiting to completed.
    • 29 Jul 2015 Status changed from not yet recruiting to recruiting, as reported by Australian New Zealand Clinical Trials Registry.
    • 12 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top